Utah Governor’s Office of Economic Development

The focus of this center is the development of technologies
which lead to the real-time detection of pathogenic micro-organisms. This involves the development of novel pathogen capture molecules, platform development, prototype development, and commercialization. Industries where this technology is useful include pharmaceuticals, biomedicine, biotechnology, veterinary, production agriculture, food processing, public health, defense, and water and sewage treatment. To date, four technologies have been developed:

1. ImmunoFlow
2. ImmunoDNA
3. GlycoBind
4. TissueTag

• The Center has licensed the ImmunoFlow technology to Stellar Technologies.
• 5 international patents issued, several more pending
• Seeking commercialization partners

• Bio Matrix Solutions
• Finite Technologies

• Stellar Technologies